Document Detail


Xamoterol monotherapy in heart failure. The European 'Corwin' Group.
MedLine Citation:
PMID:  1971596     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The effect of xamoterol as sole therapy was investigated in randomized, double-blind, placebo-controlled studies involving 425 patients with mild to moderate heart failure. When compared with placebo, xamoterol produced improvements in exercise capacity, clinical signs, symptoms and quality of life with a low incidence of adverse experiences. Xamoterol is effective as monotherapy in heart failure.
Authors:
R M Timewell; R D Stark; H F Marlow
Related Documents :
20883926 - Coenzyme q10, rosuvastatin, and clinical outcomes in heart failure: a pre-specified sub...
17075376 - Fast-track failure after cardiac surgery: development of a prediction model.
23548336 - Retrograde cardioplegia revisited: open technique for long aortic cross clamping.
12793706 - Heart failure in the elderly.
18040676 - Evaluation of postoperative pulmonary regurgitation after surgical repair of tetralogy ...
16563786 - The effect of ventricular sequential contraction on helical heart during pacing: high s...
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  European heart journal     Volume:  11 Suppl A     ISSN:  0195-668X     ISO Abbreviation:  Eur. Heart J.     Publication Date:  1990 Apr 
Date Detail:
Created Date:  1990-07-05     Completed Date:  1990-07-05     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8006263     Medline TA:  Eur Heart J     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  62-4     Citation Subset:  IM    
Affiliation:
ICI Pharmaceuticals, Macclesfield, Cheshire, U.K.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenergic beta-Agonists / adverse effects,  therapeutic use*
Aged
Cardiac Output, Low / drug therapy*
Double-Blind Method
Drug Evaluation
Humans
Propanolamines / adverse effects,  therapeutic use*
Randomized Controlled Trials as Topic
Xamoterol
Chemical
Reg. No./Substance:
0/Adrenergic beta-Agonists; 0/Propanolamines; 81801-12-9/Xamoterol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effect of xamoterol on haemodynamics and plasma catecholamines in chronic heart failure.
Next Document:  A patient-powered treadmill--a simple alternative means of assessing heart failure and treatment in ...